Added Therapeutic Benefits of Top-Selling Drugs in Japan: A Cross-Sectional Study Using Health Technology Assessment

Hakariya, Hayase; Ozaki, Akihiko; Hashimoto, Takanao; Moriarty, Frank; Maeda, Hideki; Tanimoto, Tetsuya

dc.contributor.author	Hakariya, Hayase
dc.date.accessioned	2025-09-16T09:20:10Z
dc.date.available	2025-09-16T09:20:10Z
dc.date.issued	2025
dc.identifier.issn	1752-8054
dc.identifier.uri	http://hdl.handle.net/10900/170288
dc.identifier.uri	http://dx.doi.org/10.15496/publikation-111615
dc.language.iso	en	de_DE
dc.publisher	Hoboken : Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/cts.70243	de_DE
dc.subject.ddc	610	de_DE
dc.title	Added Therapeutic Benefits of Top-Selling Drugs in Japan: A Cross-Sectional Study Using Health Technology Assessment	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_00313
utue.personen.roh	Hakariya, Hayase
utue.personen.roh	Ozaki, Akihiko
utue.personen.roh	Hashimoto, Takanao
utue.personen.roh	Moriarty, Frank
utue.personen.roh	Maeda, Hideki
utue.personen.roh	Tanimoto, Tetsuya
dcterms.isPartOf.ZSTitelID	Cts - Clinical and Translational Science	de_DE
dcterms.isPartOf.ZS-Issue	Article e70243	de_DE
dcterms.isPartOf.ZS-Volume	18 (6)	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE